These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 31419209

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
    Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, Paripovic L, Klingspor L, Nordøy I, Hamal P, Arikan Akdagli S, Ossi C, Grancini A, Cavanna C, Lo Cascio G, Scarparo C, Candoni A, Caira M, Drogari Apiranthitou M, ECMM Working Group.
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD, Heidrich D, Corrêa C, Scroferneker ML, Vettorato G, Fuentefria AM, Goldani LZ.
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [Abstract] [Full Text] [Related]

  • 9. Multidrug-resistant Fusarium in keratitis: a clinico-mycological study of keratitis infections in Chennai, India.
    Tupaki-Sreepurna A, Al-Hatmi AM, Kindo AJ, Sundaram M, de Hoog GS.
    Mycoses; 2017 Apr; 60(4):230-233. PubMed ID: 27766684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Genus Fusarium Causing Human Keratomycosis in South India.
    Hassan AS, Al-Hatmi AM, Shobana CS, van Diepeningen AD, Kredics L, Vágvölgyi C, Homa M, Meis JF, de Hoog GS, Narendran V, Manikandan P, IHFK Working Group.
    Med Mycol; 2016 Mar; 54(3):287-94. PubMed ID: 26705832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF.
    J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
    Debourgogne A, de Hoog S, Lozniewski A, Machouart M.
    Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):615-8. PubMed ID: 21744037
    [No Abstract] [Full Text] [Related]

  • 18. Fusarium keratitis in a Brazilian tropical semi-arid area: Clinical-epidemiological features, molecular identification and antifungal susceptibility.
    Milanez EPR, de Souza PFSM, Monteiro RC, Pereira LMG, Peixoto PHS, de Oliveira DFG, Colares PPR, Teixeira RF, Andrade MFCE, Silva JV, Rodrigues AM, de Souza Collares Maia DCB, Cordeiro RA.
    Mycoses; 2024 May; 67(5):e13728. PubMed ID: 38695201
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.